Chemotherapy and cognitive complaints in women with breast cancer

M.J.J. Pullens, J. de Vries, L.J.C. van Warmerdam, M.A. van de Wal, J.A. Roukema

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Background
Results of existing studies are inconclusive concerning the relationship between chemotherapy and subjective cognitive functioning (SCF). The aim of this study was to evaluate SCF of breast cancer (BC) patients and to find predictors of impaired SCF. Both satisfaction and frequency of complaints about SCF were measured.
Methods
BC patients who were about to receive chemotherapy (N = 74) and patients with a benign breast disease (BBD) (N = 63) participated. Before chemotherapy started (Time 1) and 3 months after ending chemotherapy (and at comparable moments for the BBD group) (Time 2), women completed validated questionnaires concerning the frequency of complaints and satisfaction with SCF, fatigue, perceived stress, anxiety, and depressive symptoms.
Results
No differences were found between the BBD and BC patients concerning the frequency of complaints about SCF across time. Satisfaction with SCF decreased across time in BC patients but remained stable across time in BBD patients (p < 0.001; p = 0.003 after controlling for state anxiety and perceived stress). Correlation coefficients between the satisfaction and the frequency of complaints about SCF ranged between −0.26 and −0.49. Depressive symptoms and satisfaction with SCF (Time 1) predicted the frequency of complaints about SCF (Time 2). Diagnosis, frequency of complaints about SCF, and state anxiety (Time 1) predicted satisfaction with SCF (Time 2).
Conclusions
BC patients do not differ in the frequency of complaints about SCF compared with BBD patients, but their satisfaction with SCF decreased after treatment. Psychological factors predicted the frequency of complaints about SCF. Psychological factors and diagnosis predicted satisfaction with SCF.
Original languageEnglish
Pages (from-to)1783-1789
JournalPsycho-Oncology
Volume22
Issue number8
DOIs
Publication statusPublished - 2013

Fingerprint

Depression
Surveys and Questionnaires

Cite this

Pullens, M.J.J. ; de Vries, J. ; van Warmerdam, L.J.C. ; van de Wal, M.A. ; Roukema, J.A. / Chemotherapy and cognitive complaints in women with breast cancer. In: Psycho-Oncology. 2013 ; Vol. 22, No. 8. pp. 1783-1789.
@article{5bc8a64952994cf0bdca454094e80da6,
title = "Chemotherapy and cognitive complaints in women with breast cancer",
abstract = "BackgroundResults of existing studies are inconclusive concerning the relationship between chemotherapy and subjective cognitive functioning (SCF). The aim of this study was to evaluate SCF of breast cancer (BC) patients and to find predictors of impaired SCF. Both satisfaction and frequency of complaints about SCF were measured.MethodsBC patients who were about to receive chemotherapy (N = 74) and patients with a benign breast disease (BBD) (N = 63) participated. Before chemotherapy started (Time 1) and 3 months after ending chemotherapy (and at comparable moments for the BBD group) (Time 2), women completed validated questionnaires concerning the frequency of complaints and satisfaction with SCF, fatigue, perceived stress, anxiety, and depressive symptoms.ResultsNo differences were found between the BBD and BC patients concerning the frequency of complaints about SCF across time. Satisfaction with SCF decreased across time in BC patients but remained stable across time in BBD patients (p < 0.001; p = 0.003 after controlling for state anxiety and perceived stress). Correlation coefficients between the satisfaction and the frequency of complaints about SCF ranged between −0.26 and −0.49. Depressive symptoms and satisfaction with SCF (Time 1) predicted the frequency of complaints about SCF (Time 2). Diagnosis, frequency of complaints about SCF, and state anxiety (Time 1) predicted satisfaction with SCF (Time 2).ConclusionsBC patients do not differ in the frequency of complaints about SCF compared with BBD patients, but their satisfaction with SCF decreased after treatment. Psychological factors predicted the frequency of complaints about SCF. Psychological factors and diagnosis predicted satisfaction with SCF.",
author = "M.J.J. Pullens and {de Vries}, J. and {van Warmerdam}, L.J.C. and {van de Wal}, M.A. and J.A. Roukema",
year = "2013",
doi = "10.1002/pon.3214",
language = "English",
volume = "22",
pages = "1783--1789",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "Wiley",
number = "8",

}

Chemotherapy and cognitive complaints in women with breast cancer. / Pullens, M.J.J.; de Vries, J.; van Warmerdam, L.J.C.; van de Wal, M.A.; Roukema, J.A.

In: Psycho-Oncology, Vol. 22, No. 8, 2013, p. 1783-1789.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Chemotherapy and cognitive complaints in women with breast cancer

AU - Pullens, M.J.J.

AU - de Vries, J.

AU - van Warmerdam, L.J.C.

AU - van de Wal, M.A.

AU - Roukema, J.A.

PY - 2013

Y1 - 2013

N2 - BackgroundResults of existing studies are inconclusive concerning the relationship between chemotherapy and subjective cognitive functioning (SCF). The aim of this study was to evaluate SCF of breast cancer (BC) patients and to find predictors of impaired SCF. Both satisfaction and frequency of complaints about SCF were measured.MethodsBC patients who were about to receive chemotherapy (N = 74) and patients with a benign breast disease (BBD) (N = 63) participated. Before chemotherapy started (Time 1) and 3 months after ending chemotherapy (and at comparable moments for the BBD group) (Time 2), women completed validated questionnaires concerning the frequency of complaints and satisfaction with SCF, fatigue, perceived stress, anxiety, and depressive symptoms.ResultsNo differences were found between the BBD and BC patients concerning the frequency of complaints about SCF across time. Satisfaction with SCF decreased across time in BC patients but remained stable across time in BBD patients (p < 0.001; p = 0.003 after controlling for state anxiety and perceived stress). Correlation coefficients between the satisfaction and the frequency of complaints about SCF ranged between −0.26 and −0.49. Depressive symptoms and satisfaction with SCF (Time 1) predicted the frequency of complaints about SCF (Time 2). Diagnosis, frequency of complaints about SCF, and state anxiety (Time 1) predicted satisfaction with SCF (Time 2).ConclusionsBC patients do not differ in the frequency of complaints about SCF compared with BBD patients, but their satisfaction with SCF decreased after treatment. Psychological factors predicted the frequency of complaints about SCF. Psychological factors and diagnosis predicted satisfaction with SCF.

AB - BackgroundResults of existing studies are inconclusive concerning the relationship between chemotherapy and subjective cognitive functioning (SCF). The aim of this study was to evaluate SCF of breast cancer (BC) patients and to find predictors of impaired SCF. Both satisfaction and frequency of complaints about SCF were measured.MethodsBC patients who were about to receive chemotherapy (N = 74) and patients with a benign breast disease (BBD) (N = 63) participated. Before chemotherapy started (Time 1) and 3 months after ending chemotherapy (and at comparable moments for the BBD group) (Time 2), women completed validated questionnaires concerning the frequency of complaints and satisfaction with SCF, fatigue, perceived stress, anxiety, and depressive symptoms.ResultsNo differences were found between the BBD and BC patients concerning the frequency of complaints about SCF across time. Satisfaction with SCF decreased across time in BC patients but remained stable across time in BBD patients (p < 0.001; p = 0.003 after controlling for state anxiety and perceived stress). Correlation coefficients between the satisfaction and the frequency of complaints about SCF ranged between −0.26 and −0.49. Depressive symptoms and satisfaction with SCF (Time 1) predicted the frequency of complaints about SCF (Time 2). Diagnosis, frequency of complaints about SCF, and state anxiety (Time 1) predicted satisfaction with SCF (Time 2).ConclusionsBC patients do not differ in the frequency of complaints about SCF compared with BBD patients, but their satisfaction with SCF decreased after treatment. Psychological factors predicted the frequency of complaints about SCF. Psychological factors and diagnosis predicted satisfaction with SCF.

U2 - 10.1002/pon.3214

DO - 10.1002/pon.3214

M3 - Article

VL - 22

SP - 1783

EP - 1789

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 8

ER -